Open AccessP569: GILTERITINIB AND QUIZARTINIB IN RELAPSED/REFRACTORY (R/R) ACUTE MYELOBLASTIC LEUKEMIA (AML) WITH FLT3 MUTATIONS: A REAL‐LIFE EFFECTIVENESS AND SAFETY STUDY
Author(s) -
Quintela D.,
Morgades M.,
Serrano A.,
Cervera M.,
Balerdi A.,
DíazBeyá M.,
Arnan M.,
Garrido A.,
Coll R.,
Tormo M.,
LópezMarin J.,
Merchan B.,
Garcia S.,
Casado M.,
Sampol A.,
Esteve J.,
MartínezCuadrón D.,
Sierra J.,
Sanz M. Á.,
Ribera J. M.,
Montesinos P.,
Vives S.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845164.12158.18
Subject(s) - midostaurin , medicine , context (archaeology) , refractory (planetary science) , dacarbazine , gastroenterology , chemotherapy , oncology , leukemia , biology , paleontology , astrobiology